VANCOUVER and MINNEAPOLIS, MN, Nov. 05, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc.("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement …
CymaBay announces trial design for RESPONSE, a global phase 3 registration study for seladelpar in primary biliary cholangitis (PBC) Results from the ENHANCE phase 3 study evaluating seladelpar for PBC to be featured in an oral, late-breaking presentation …
Revenue: $636 million, up 10% from the third quarter of 2019 EBITDA Margin: 9.0% Diluted EPS: $0.73, up 6% from the third quarter of 2019 Adjusted Diluted EPS: $0.83, up 6% from the third quarter of 2019 Bookings of $1.3 billion resulting in a book-to-bill …
EL SEGUNDO, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- A-Mark Precious Metals, Inc. (NASDAQ: AMRK), a leading full-service provider of products and services to the global precious metals market, will hold a conference call on Tuesday, November 10 at 4:30 p. …
Exceeds high end of revenue and adjusted EBITDA guidance Outlines priorities to unlock shareholder value CHARLESTON, S.C., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Benefitfocus, Inc. (NASDAQ: BNFT), an industry-leading benefits technology platform that …
Generated Total Revenues of $28.3 Million for the First Nine Months of 2020, Reflecting a 63% Increase Over the Same Prior Year Period Successfully Opened Newest ADMA BioCenters Plasma Collection Facility; On Track to Achieve Stated Goal of Opening Five to …
BERKELEY HEIGHTS, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory …
Third Quarter Total Revenue of $39.7 Million, an Increase of 41% Versus Prior Year Total ARR of $167.0 Million, an Increase of 38% Versus Prior Year AUSTIN, Texas, Nov. 05, 2020 (GLOBE NEWSWIRE) -- BigCommerce Holdings, Inc. (“BigCommerce”) (Nasdaq: BIGC …
FOSTER CITY, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today reported financial results for the third quarter ended September 30, 2020. The Company will host a conference …
SUNNYVALE, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Infinera Corporation (NASDAQ: INFN) today released financial results for its third quarter ended September 26, 2020. GAAP revenue for the quarter was $340.2 million compared to $331.6 million in the …
Third quarter 2020 total revenues of $20.2 million, a 45% increase over third quarter 2019 Third quarter 2020 GOCOVRI® product sales of $19.0 million, a 36% increase over third quarter 2019 Total paid prescriptions of 7,930, a 19% increase over third …
SANTA MONICA, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- TrueCar, Inc. (NASDAQ: TRUE) today announced its financial results for the third quarter ended September 30, 2020. Third Quarter 2020 Financial Highlights The following financial results reflect …
-- Recovering Business Activity Led to Substantial Improvement in Gross Profit over Q2-- --Year-to Date Operating Cash Flow of $27.9MM and Free Cash Flow of $18.9MM-- --Positive New Business Momentum Reflects Scale and Demand for New Technology Offerings-- …
– Company plans to file IND for Ziopharm TCR-T program in Q1 of next year for its Library “hotspot” trial – – Eden BioCell on track for IND filing in Taiwan for autologus CAR-T clinical trial this year based on rapid personalized manufacturing; several …
SOUTH SAN FRANCISCO, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today announced its participation at these …
EDIT-101 for LCA10 ‒ BRILLIANCE trial adult low-dose cohort completed EDIT-301 for sickle cell disease ‒ on track for IND filing by end of 2020 EDIT-201 for solid tumors ‒ preclinical data to be presented at SITC and ASH Cash, cash equivalents, and …
Q1’21 Financial Results and Recent Business Highlights Revenue of $328.4 million GAAP Gross Margin of 41.0 percent; non-GAAP Gross Margin of 49.7 percent GAAP diluted loss per share of $0.08; non-GAAP diluted earnings per share of $1.85 Cash and short-term …
SOUTH SAN FRANCISCO, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the …
TORONTO, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic Resonance Imaging (“MRI”), thermal …
BOCA RATON, Fla., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological …
07 days 19:45:01
